Literature DB >> 10023665

Downregulation of metallothionein-IIA expression occurs at immortalization.

E L Duncan1, R R Reddel.   

Abstract

Metallothioneins (MTs) may modulate a variety of cellular processes by regulating the activity of zinc-binding proteins. These proteins have been implicated in cell growth regulation, and their expression is abnormal in some tumors. In particular, MT-IIA is expressed 27-fold less in human colorectal tumors and tumor cell lines compared with normal tissue (Zhang et al., 1997). Here we demonstrate that MT-IIA downregulation occurs when human cells become immortal, a key event in tumorigenesis. After immortalization MT-IIA expression remains inducible but the basal activity of the MT-IIA promoter is decreased. MT-IIA downregulation at immortalization is one of the most common immortalization-related changes identified to date, suggesting that MT-IIA has a role in this process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023665     DOI: 10.1038/sj.onc.1202370

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma.

Authors:  Klaus Jürgen Schmitz; Carmen Ina Müller; Henning Reis; Hakan Alakus; Günther Winde; Hideo Andreas Baba; Jeremias Wohlschlaeger; Bharat Jasani; Joachim Fandrey; Kurt Werner Schmid
Journal:  Int J Colorectal Dis       Date:  2009-06-16       Impact factor: 2.571

3.  Suppression of metallothionein-I/II expression and its probable molecular mechanisms.

Authors:  Samson T Jacob; Sarmila Majumder; Kalpana Ghoshal
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

4.  Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.

Authors:  Yuanming Pan; Jiaqiang Huang; Rui Xing; Xin Yin; Jiantao Cui; Wenmei Li; Jun Yu; Youyong Lu
Journal:  J Transl Med       Date:  2013-07-19       Impact factor: 5.531

5.  Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk.

Authors:  Jianguo Wang; Pinghua Huang; Wei Zhao; Wei Ren; Ling Ai; Liping Wu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

6.  Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma.

Authors:  P Coyle; G Mathew; P A Game; J C Myers; J C Philcox; A M Rofe; G G Jamieson
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.